Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $9.88 USD
Change Today -0.32 / -3.14%
Volume 703.9K
MACK On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James H. Quigley

Director and Chairman of Audit Committee,Merrimack Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 284 board members in 7 different organizations across 8 different industries.

See Board Relationships


Mr. James H. Quigley, also known as Jim, serves as the Co-Chairman of the TransAtlantic Business Dialogue. He has been an Independent Director at Hess Corporation since May 16, 2013 and Wells Fargo & Company since October 22, 2013. He has been a Director of Wells Fargo & Company since October 22, 2013. He serves as a Trustee of The German Marshall Fund of the United States. He has been a Director of Merrimack Pharmaceuticals, Inc. since July 12, 2012. He serves as a ...

Read Full Background

Corporate Headquarters*

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-441-1000
Fax: 617-491-1386

Board Members Memberships*

Director and Chairman of Audit Committee
Independent Director, Chairman of Audit Committee, Chairman of Subcommittee On Environmental, Health & Safety Matters, Member of Executive Committee and Member of Compensation & Management Development Committee
Director, Chairman of Audit & Examination Committee, Member of Risk Committee, and Member of Credit Committee


Honorary Doctorate
Bentley University
Honorary Doctorate
Utah State University
Utah State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$175,773
Total Calculated Compensation$350,775
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $9.88 USD -0.32


Jack B. Moore Chairman and Chief Executive Officer
Cameron International Corporation
John J. Christmann IVChief Executive Officer, President and Director
Apache Corp.
Scott Douglas Sheffield Chairman and Chief Executive Officer
Pioneer Natural Resources Co.
Peter J. Coleman BEng, MBAChief Executive Officer, Managing Director and Director
Woodside Petroleum Ltd.
Toshiaki Kitamura Chief Executive Officer, President, Representative Director and Member of CSR Committee
Inpex Corporation
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at